INITIAL ESTABLISHMENT OF A PROTOCOL FOR ISOLATING EXOSOME FROM THE CULTURE MEDIUM OF ADIPOSE TISSUE- DERIVED MESENCHYMAL STEM CELLS FOR APPLICATIONS IN REGENERATIVE MEDICINE
Main Article Content
Abstract
Background: Exosome is opening a new direction in regenerative medicine with the ability to support, repair, and restore damaged tissue. Their potential in improving health and treating complex diseases is enormous. In the future, exosome may become a powerful and popular tool in regenerative medicine. Objectives: To initially establish a process for isolating, collecting, and identifying exosome sources to provide a standardized and safe source of exosome for research in biology and medicine. Materials and methods: Mesenchymal stem cells were isolated and expanded from human adipose tissue. The cultured cell supernatant was then used as the source material for exosome isolation. The resulting exosome product was identified based on morphology, size, and surface protein expression according to ISEV standards. The exosome product was also quantified for protein concentration using the Bradford method, and its safety was assessed for sterility and the presence of some heavy metals. Results: The exosome product after collection contained spherical exosome, with particle sizes ranging from 30 to 200 nm. By flow cytometry, the exosome particles expressed CD9, CD63, and CD81 proteins. The exosome solution had a concentration of about 45.22 µg/ml and did not contain some heavy metals surveyed, such as Lead, Cadmium, Arsenic, and Mercury. Conclusion: The exosome product solution meets ISEV international standards, ensuring safety and quality, especially for studies aimed at regenerative medicine.
Keywords
Mesenchymal stem cells, exosome, regenerative medicine
Article Details
References
2. Chen J., Li P., Zhang T., Xu Z., Huang X., et al. Review on Strategies and Technologies for Exosome Isolation and Purification. Frontiers in Bioengineering and Biotechnology. 2022. 9 (811971), 1-18. doi: 10.3389/fbioe.2021.811971.
3. Huỳnh Duy Thảo, Trần Lê Bảo Hà, Lê Thanh Hùng, Võ Quốc Vũ, Hoàng Kc Hương và cộng sự. Nghiên cứu quy trình thu nhận tế bào gốc trung mô từ mô mỡ người hướng đến ứng dụng trong lĩnh vực y học. Y Học TP. Hồ Chí Minh. 2013. 17(2), 133-140.
4. Sidhom K., Obi P.O., and Saleem A. A Review of Exosomal Isolation Methods: Is Size Exclusion Chromatography the Best Option? International Journal of Molecular Sciences. 2020. 21(18), 1-19. doi: 10.3390/ijms21186466.
5. Hoang Huong Diem, Bui Thi Van Khanh, Hoang Thi My Nhung, Nguyen Thanh Liem, Than Thi Trang Uyen. Initial characterisation of exosomes released by umbilical cord-derived mesenchymal stem cells and mature dendritic cells, under ‘Good Manufacturing Practice’ conditions. Vietnam Journal of Science, Technology and Engineering. 2019. 61(3), 45-51. doi:
10.31276/VJSTE.
6. Nam HB Tran, Diem DN Nguyen, Ngoc Mai Nguyen, Chau Tran, Ngoc Thanh Nguyen Thi et al. Dual-targeting exosomes for improved drug delivery in breast cancer. Nanomedicine. 2023. 18(7), 599-611. doi: 10.2217/nnm-2022-0328.
7. Yang Q., Li S., Ou H., Zhang Y., Zhu G., et al. Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application. Journal of Nanobiotechnology. 2024. 22(1), 1-41. doi: 10.1186/s12951-024-02298-7.
8. Zhou T., He C., Lai P., Yang Z., Liu Y., et al. miR-204-containing exosomes ameliorate
GVHD-associated dry eye disease. Science advances. 2022. 8(2), 1-14. doi: 10.1126/sciadv.abj9617.
9. Adelipour M., Lubman D.M., and Kim J. Potential applications of mesenchymal stem cells and their derived exosomes in regenerative medicine. Expert Opinion on Biological Therapy. 2023. 23(6), 491-507. doi: 10.1080/14712598.2023.2211203.
10. Lopes D., Lopes J., Pereira-Silva M., Peixoto D., Rabiee N., et al. Bioengineered exosomalmembrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine. Military medical research. 2023. 10(1), 1-26. doi: 10.1186/s40779023-00453-z.